We acknowledge that further work is needed to explore this population’s perceptions of and experiences with the end-of-life care system. We completed preliminary interviews (n=5) with homeless persons receiving care at a low-threshold hospice but suspended

this part of our study due to concerns about the quality of data (e.g., consistency of accounts, recall of events, etc.). Future research, and especially that aiming to identify ways to improve the end-of-life care system, could benefit from better drawing upon the experiences of homeless end-of-life care Inhibitors,research,lifescience,medical recipients. Conclusions This article documented health and GDC-0973 nmr Social services professionals views of the barriers that homeless persons face to accessing the end-of-life care system, as well as recommendations to improve access to this system for this population. While participants identified several barriers (i.e., insufficient availability of services, exclusionary operating policies, and poor continuity of care), they made key recommendations

for improving the Inhibitors,research,lifescience,medical end-of-life Inhibitors,research,lifescience,medical care system for this population. In particular, participants identified the importance of structural changes to the delivery of end-of-life care services, emphasizing the importance of expanding services, integrating harm reduction approaches, and fostering partnerships with the public health system. These observations have the potential to be translated into policy and programmatic responses, notably the expansion of end-of-life care services, implementation of patient advocate Inhibitors,research,lifescience,medical programs, and adoption of harm reduction policies. For policymakers and health administrators concerned with increasing equity in the end-of-life care system for homeless Inhibitors,research,lifescience,medical populations, these recommendations

present a possible way forward. Competing interests The authors declare that they have no competing interests. Authors’ contributions MGY and RM designed the study and conducted data collection. All authors contributed to the data analysis. RM wrote the first draft of the manuscript. All authors contributed to the critical revision and approved the final content. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1472-684X/11/14/prepub Acknowledgements We would like to first and foremost thank Chlormezanone our study participants for sharing their insights and experiences with us. We would also like to acknowledge the contributions of study collaborators: Tim Aubry, Stephen Hwang, Frances Legault, Vivien Runnels and Jeffrey Turnbull. Peggy Cooke, Natalie Dupuis, and Arash Kameli provided research and administrative support. We thank the reviewers (Isolde Daiski and Edward Ratner) for their helpful feedback. Ryan McNeil is supported by a doctoral award from the Social Science and Humanities Research Council.